We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2−) early breast cancer (EBC): results from the GEICAM/2006–10 study.
- Authors
Ruíz-Borrego, Manuel; Guerrero-Zotano, Angel; Bermejo, Begoña; Ramos, Manuel; Cruz, Josefina; Baena-Cañada, Jose Manuel; Cirauqui, Beatriz; Rodríguez-Lescure, Álvaro; Alba, Emilio; Martínez-Jáñez, Noelia; Muñoz, Montserrat; Antolín, Silvia; Álvarez, Isabel; Del Barco, Sonia; Sevillano, Elena; Chacón, José Ignacio; Antón, Antonio; Escudero, María José; Ruiz, Victoria; Carrasco, Eva
- Publication
Breast Cancer Research & Treatment, 2019, Vol 177, Issue 1, p115
- ISSN
0167-6806
- Publication type
Article
- DOI
10.1007/s10549-019-05296-8